Exact Mass: 544.3916242
Exact Mass Matches: 544.3916242
Found 227 metabolites which its exact mass value is equals to given mass value 544.3916242,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ganoderic acid Mj
Ganoderic acid Mj is found in mushrooms. Ganoderic acid Mj is a metabolite of Ganoderma lucidum (reishi Metabolite of Ganoderma lucidum (reishi). Ganoderic acid Mj is found in mushrooms.
Ganoderic acid Mi
Ganoderic acid Mi is found in mushrooms. Ganoderic acid Mi is a metabolite of Ganoderma lucidum (reishi Metabolite of Ganoderma lucidum (reishi). Ganoderic acid Mi is found in mushrooms.
DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)
DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))
DG(8:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/8:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)
DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))
DG(8:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/8:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)
DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))
DG(8:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/8:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)
DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))
DG(8:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/8:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)
DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))
DG(8:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/8:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
22-Acetoxy-3alpha-hydroxy-7alpha-methoxylanosta-8,24E-dien-26-oic acid
(2S,3R,6R)-1-acetyl-2-[3,6-diacetoxyeicosanyl]glycerol|oncidinol
16beta-methoxyalisol B 23-acetate|16beta-Methoxyalisol B monoacetate
24-methylenecholesterol-3-O-alpha-L-fucopyranoside
3alpha-acetoxy-21R-methoxy-17alpha-20S-21,23R-epoxyapotirucall-14,25-dien-7alpha,24R-diol|chisopanin C
D:C-friedo-oleana-7,9(11)-diene-3alpha,29-diol 3-benzoate|karounidiol 3-benzoate|Karounidiol 3-o-benzoate|multiflora-7,9(11)-diene-3alpha,29-diol 3-benzoate
3beta-acetoxy-12beta-methoxy-7,8-dihydroholothurinogenin
1,3-di-O-acetyl-2-O-[(3R,6S)-3-(acetyloxy)-6-hydroxyeicosanoyl]glycerol
1-O-acetyl-2-O-[(3R,8R)-3,8-bis(acetyloxy)eicosanoyl]-sn-glycerol
(2alpha,3alpha)-2,29-dihydroxy-3,23-[(1,1-dimethylmethylene)dioxy]olean-12-en-28-oic acid|stachlic acid B
cavalerol J|methyl (3beta,6beta,11beta,17epsilon,21beta)-6-(acetyloxy)-3,11-dihydroxyhop-22(29)-en-24-oate|methyl 6beta-(acetyloxy)-3beta,11beta-dihydroxy-21alphaH-hop-22(29)-en-24-oate
2-Ac,Me ester-2,3,23-(2alpha,3beta)-Trihydroxy-12-oleanen-28-oic acid
cryptocaryol C
A member of the class of 2-pyranones that is 5,6-dihydro-2H-pyran-2-one substituted by a hydroxy group at position 5 and a 2,4,6,8,10-pentahydroxypentacosyl group at position 6. It has been isolated from Cryptocarya species.
(20S)-2alpha,4beta-bis(acetoxy)-20-(N,N-dimethylamino)-3beta-tigloylamino-5alpha-pregnane
3beta-benzoyloxy-12(13)-ursene-11-one|3beta-Benzoyloxy-urs-12-en-11-on|3beta-benzoyloxy-urs-12-en-11-one|3beta-Benzoyloxy-ursen-(12)-on-(11)|Neoilexonol-benzoat
(2alpha,3beta,4beta,20S)-2,4-bis(acetoxy)-20-(N,N-dimethylamino)-3-[(3-methylbut-2-enoyl)amino]-5alpha-pregnane
2alpha-acetoxy-3beta,24-epoxy-3alpha-hydroxy-D:A-friedooleanan-29-oic acid methyl ester
1-O-acetyl-2-O-[(3R,7R)-3,7-bis(acetyloxy)eicosanoyl]-sn-glycerol
1-O-acetyl-2-O-[(3R,9R)-3,9-bis(acetyloxy)eicosanoyl]-sn-glycerol
Ile Arg Arg Thr
Ile Arg Thr Arg
Ile Thr Arg Arg
Lys Lys Asn Arg
Lys Lys Arg Asn
Lys Asn Lys Arg
Lys Asn Arg Lys
Lys Arg Lys Asn
Lys Arg Asn Lys
Leu Arg Arg Thr
Leu Arg Thr Arg
Leu Thr Arg Arg
Asn Lys Lys Arg
Asn Lys Arg Lys
Asn Arg Lys Lys
Arg Ile Arg Thr
Arg Ile Thr Arg
Arg Lys Lys Asn
Arg Lys Asn Lys
Arg Leu Arg Thr
Arg Leu Thr Arg
Arg Asn Lys Lys
Arg Arg Ile Thr
Arg Arg Leu Thr
Arg Arg Thr Ile
Arg Arg Thr Leu
Arg Thr Ile Arg
Arg Thr Leu Arg
Arg Thr Arg Ile
Arg Thr Arg Leu
Thr Ile Arg Arg
Thr Leu Arg Arg
Thr Arg Ile Arg
Thr Arg Leu Arg
Thr Arg Arg Ile
Thr Arg Arg Leu
11α-Hemiglutaryloxy-1,25-dihydroxyvitamin D3
Ganoderic acid Mi
Ganoderic acid Mj
N-(15-methyl-3-hydroxy-hexadecanoyl)-glycyl-seryl-ornithine
11alpha-Hemiglutaryloxy-1,25-dihydroxyvitamin D3
1,4,8,11-Tetrakis(ethoxycarbonylmethyl)-1,4,8,11-tetraazacyclotetradecane
Leupeptin hemisulfate salt
C20H38N6O4.1/2H2SO4 (544.419312)
Leupeptin hemisulfate is a broad-spectrum, membrane-permeable protease inhibitor. Leupeptin hemisulfate potently inhibits serine, cysteine and threonine proteases. Leupeptin hemisulfate inhibits Mpro (the main protease of SARS-CoV-2) and also has anti-inflammatory activity[1][2][3].
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
C30H48N4O5 (544.3624517999999)
1-cyclohexyl-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-(4-oxanylmethyl)-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C30H48N4O5 (544.3624517999999)
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
C30H48N4O5 (544.3624517999999)
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
C30H48N4O5 (544.3624517999999)
N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
C30H48N4O5 (544.3624517999999)
N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
C30H48N4O5 (544.3624517999999)
[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxyheptadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E,12E)-3-hydroxy-2-(octanoylamino)pentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)octadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)icosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxyhexadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E,12E)-2-acetamido-3-hydroxyhenicosa-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E,12E)-2-(butanoylamino)-3-hydroxynonadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[(4E,8E,12E)-3-hydroxy-2-(nonanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenoic acid
[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(1-hydroxy-3-undecanoyloxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
(1-hydroxy-3-tridecanoyloxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
4-[1,3-Bis(5-tert-butyl-4-hydroxy-2-methylphenyl)butyl]-5-tert-butyl-2-methylphenol
(1-hydroxy-3-nonanoyloxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
[1-Carboxy-3-[2,3-di(decanoyloxy)propoxy]propyl]-trimethylazanium
[1-carboxy-3-[3-[(7E,9E,11E,13E,15E,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
C32H50NO6+ (544.3637940000001)
(3-hydroxy-2-pentadecanoyloxypropyl) (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate
[3-hydroxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
[3-hydroxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[3-hydroxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropyl] (4E,7E)-hexadeca-4,7-dienoate
[(2S)-3-hydroxy-2-undecanoyloxypropyl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate
[1-Carboxy-3-(2-dodecanoyloxy-3-octanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(2-heptadecanoyloxy-3-propanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(2-pentadecanoyloxy-3-pentanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(3-heptanoyloxy-2-tridecanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(3-nonanoyloxy-2-undecanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(3-hexanoyloxy-2-tetradecanoyloxypropoxy)propyl]-trimethylazanium
[3-(3-Butanoyloxy-2-hexadecanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium
[3-(3-Acetyloxy-2-octadecanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium
2-[carboxy-[2-hydroxy-3-[(Z)-icos-11-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
TG(31:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
TG(30:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved